50% off Premium Yearly

NYSE:IBM
This summary was created by AI, based on 24 opinions in the last 12 months.
IBM Common Stock, represented by the symbol IBM-N, has brought forward mixed sentiments among experts. While some express optimism over its long-term potential, particularly in AI and quantum computing, others highlight recent disappointing earnings and significant stock price drops. In terms of valuation, the stock trades at multiples ranging from 18x to 22x PE, leading to some experts suggesting it may be overvalued, especially considering its historical performance and recent volatility. Many experts also draw attention to its transition from hardware to services that could indicate a more sustainable business model. The overall sentiment suggests cautious optimism, with some experts advocating for buying during dips and others recommending to wait for clearer signals of recovery.
Looking at the chart, he sees it at the 200 day moving average which could represent some support level. Some of the more recent earnings reports weren’t as robust as the market wanted so the stock sold off a bit. Have reaffirmed full-year guidance. As a long-term stock, this is trading at 12.5X earnings with a long-term growth of high single digit/low double-digit. A decent buy at 1.3 PEG ratio.
Really good quality mature tech choice. A few years ago, management said that with a combination of modest growth and aggressive cost-cutting, they were going to have a 12%-14% target on earnings. Have hit right on. Turned the business into a recurring revenue and a recurring earnings type of business. Valuation isn’t stretched.
Consistent generator of cash flow. It is trading cheap, at the low end of a positive growth channel. It is a buying opportunity.